{
  "meta": {
    "title": "Adrenal_Disorders_Mini_Test_-_Tmt",
    "url": "https://brainandscalpel.vercel.app/adrenal-disorders-mini-test-tmt-15180296.html",
    "scrapedAt": "2025-11-30T12:46:46.820Z"
  },
  "questions": [
    {
      "text": "A 35-year-old man presents with persistent hypertension despite being on three different antihypertensive drugs. He also complains of muscle weakness and frequent headaches. On examination, his blood pressure is 160/110 mm of Hg, and laboratory tests reveal hypokalemia. Which of the following is the most appropriate initial test in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Cosyntropin test"
        },
        {
          "id": 2,
          "text": "Saline infusion test"
        },
        {
          "id": 3,
          "text": "Aldosterone-renin ratio"
        },
        {
          "id": 4,
          "text": "Plasma ACTH levels"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The clinical presentation of <strong>hypokalemia</strong> and <strong>treatment-resistant hypertension</strong> points to a diagnosis of <strong>primary hyperaldosteronism</strong>. The initial test for this condition is the concurrent measurement of <strong>plasma renin</strong> and<strong> aldosterone</strong>, followed by the calculation of the <strong>aldosterone-renin ratio (ARR)</strong>.</p>\n<p>Primary hyperaldosteronism, also known as Conn’s syndrome, is characterized by <strong>excessive production of aldosterone</strong> by the adrenal glands, leading to <strong>sodium retention, potassium excretion, and subsequent hypertension.</strong> Drug-resistant hypertension is a <strong>hallmark</strong> of this condition. The symptom of muscle weakness in this patient is most likely due to hypokalemia.</p>\n<p>The aldosterone-renin ratio is the <strong>most appropriate screening test</strong> for primary hyperaldosteronism, this can be followed by a <strong>saline infusion test</strong> (Option B), which is used to <strong>confirm the diagnosis</strong> of Conn’s syndrome.</p>\n<p>Other options:</p>\n<p>Option A: <strong>Cosyntropin test </strong>detects <strong>adrenal insufficiency</strong> by measuring cortisol response to synthetic ACTH (Cosyntropin).</p>\n<p>Option D: Measuring <strong>plasma ACTH levels </strong>helps diagnose <strong>adrenal insufficiency or Cushing’s syndrome.</strong> It is not useful in suspected hyperaldosteronism.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6494",
      "difficulty": "medium"
    },
    {
      "text": "A 3-weeks-old infant diagnosed with primary adrenal insufficiency presented with failure to thrive, recurrent vomiting, and hepatosplenomegaly. Radiological imaging shows bilateral adrenal calcification. Enzyme studies revealed a deficiency of lysosomal acid lipase. What is the most likely disease in this case?",
      "choices": [
        {
          "id": 1,
          "text": "Hurler's disease"
        },
        {
          "id": 2,
          "text": "Scheie's disease"
        },
        {
          "id": 3,
          "text": "Wolman's disease"
        },
        {
          "id": 4,
          "text": "I cell disease"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>An infant with primary adrenal insufficiency with hepatosplenomegaly, recurrent emesis, and bilateral adrenal calcification is suggestive of <strong>Wolman's disease. </strong>It is due to the deficiency of the enzyme <strong>acid lipase. </strong></p>\n<p>It is a lipid disorder caused by a <strong>deficiency of lysosomal acid lipase</strong> (chromosome 10) which leads to the accumulation of cholesterol esters and triglycerides in the most visceral organs. It is an <strong>Autosomal recessive </strong>disease<strong>. </strong></p>\n<p>The child presents in the first few weeks of life with failure to thrive, vomiting, abdominal distention, steatorrhea, <strong>hepatosplenomegaly,</strong> and <strong>hyperlipidemia with</strong> <strong>extensive bilateral calcifications of the adrenal glands</strong>.No specific therapy is available and death usually occurs within 6 months of life.</p><hr><h3>Related Pearl: MPS and Their Respective Enzyme Deficiencies</h3><table>\n<tbody>\n<tr>\n<td><strong>Disease</strong></td>\n<td><strong>MPS</strong></td>\n<td><strong>Enzyme defective</strong></td>\n<td><strong>GAGs affected</strong></td>\n<td><strong>Symptoms</strong></td>\n</tr>\n<tr>\n<td>Hurler-, Scheie-,&nbsp;<br />Hurler-scheie syndrome</td>\n<td>MPS I</td>\n<td>&alpha;-L-Iduronidase</td>\n<td>\n<p>Dermatan sulfate,<br />Heparan sulfate</p>\n</td>\n<td>Mental retardation,<br />coarse facial features,&nbsp;<br />Hepatosplenomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Hunter syndrome</td>\n<td>MPS II</td>\n<td>Iduronate sulfatase</td>\n<td>Dermatan sulfate,&nbsp;<br />Heparan sulfate</td>\n<td>Mental retardation</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome A</td>\n<td>MPS IIIA</td>\n<td>Heparan sulfate-N-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>Delay in development<br />Motor dysfunction</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome B</td>\n<td>MPS III B</td>\n<td>&alpha;-N-Acetylglucosaminidase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome C</td>\n<td>MPS III C</td>\n<td>&alpha;-glucosaminide N-acetyltransferase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Sanfilippo&nbsp;syndrome D</td>\n<td>MPS III D</td>\n<td>N-acetylglucosamine 6-sulfatase</td>\n<td>Heparan sulfate</td>\n<td>As MPS III A &nbsp;</td>\n</tr>\n<tr>\n<td>Morquio syndrome A</td>\n<td>MPS IV A</td>\n<td>Galactosamine&nbsp;6-sulfatase</td>\n<td>Keratan sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;</td>\n<td>Skeletal dysplasia<br />short stature</td>\n</tr>\n<tr>\n<td>Morquio syndrome B</td>\n<td>MPS IV B</td>\n<td>&beta;-galactosidase</td>\n<td>Keratan sulfate</td>\n<td>As MPS IV A</td>\n</tr>\n<tr>\n<td>Maroteaux-lamy&nbsp;syndrome&nbsp;</td>\n<td>MPS VI</td>\n<td>N-acetylgalactosamine 4-sulfatase</td>\n<td>Dermatan sulfate</td>\n<td>Curvature of the spine,<br />Short stature<br />Skeletal dysplasia<br />Cardiac defects</td>\n</tr>\n<tr>\n<td>Sly&nbsp;syndrome&nbsp;</td>\n<td>MPS VII</td>\n<td>&beta;-glucuronidase</td>\n<td>Dermatan sulfate<br />Heparan sulfate<br />Chondroitin 4-sulfate&nbsp;<br />Chondroitin 6-sulfate&nbsp;<br /><br /></td>\n<td>Short stature<br />Skeletal dysplasia<br />Hepatomegaly<br />Cloudy cornea</td>\n</tr>\n<tr>\n<td>Natowicz&nbsp;syndrome&nbsp;</td>\n<td>MPS IX</td>\n<td>Hyaluronidase</td>\n<td>Hyaluronic acid</td>\n<td>Joint Pain<br />Short stature&nbsp;</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Diseases due to glycoprotein defect</h3><table>\n<tbody>\n<tr>\n<td><strong>Diseases</strong></td>\n<td><strong>Defect</strong></td>\n<td><strong>Characteristics</strong></td>\n</tr>\n<tr>\n<td>I-cell disease</td>\n<td>Mutation in GNPTA gene leading to a deficiency in enzyme UDP-N-acetylglucoseamine-1-phosphotransferase</td>\n<td>\n<ul>\n<li>Coarse facial features</li>\n<li>Corneal erosion</li>\n<li>Failure to thrive</li>\n<li>Hepatomegaly</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Leukocyte adhesion deficiency, type II</td>\n<td>Mutations affecting activity of Golgi-located GDP-fucose transporter </td>\n<td>\n<ul>\n<li>Neutrophil rolling</li>\n<li>Life-threatening, recurrent bacterial infections</li>\n<li>Psychomotor and mental retardation</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Paroxysmal nocturnal hemoglobinuria</td>\n<td>Genetic mutation leading to the inability to synthesize the glycosyl-phosphatidylinositol (GPI) anchor that binds certain surface proteins to cell membranes.</td>\n<td>\n<ul>\n<li>Lysis of red cells</li>\n<li>Abdominal pain</li>\n<li>Back pain</li>\n<li>Esophageal spasms</li>\n<li>Erectile dysfunction</li>\n<li>Fatigue</li>\n<li>Progressive chronic renal failure</li>\n<li>Thrombophilia</li>\n<li>Bone marrow failure</li>\n<li>Venous thrombosis</li>\n<li>Aplastic anemia</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Ehlers–Danlos syndrome</td>\n<td>Deficiency or mutation in Lysyl hydroxylase-1  </td>\n<td>\n<ul>\n<li>Neonatal kyphoscoliosis</li>\n<li>Generalized joint laxity</li>\n<li>Skin fragility</li>\n<li>Severe muscle hypotonia at birth</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Oligosaccharidoses</td>\n<td>Lack of a specific lysosomal hydrolase for glycoproteins</td>\n<td>\n<ul>\n<li>Delay in intellectual and physical development.</li>\n<li>Seizure</li>\n<li>Joint stiffness and pain</li>\n<li>Problems with vision and hearing</li>\n<li>Anaemia, nose bleeds, and easy bleeding or bruising</li>\n<li>Swollen abdomen due to enlarged spleen or liver. </li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Congenital disorders of glycosylation  </td>\n<td>Glycosylation of a variety of tissue proteins and/or lipids is deficient or defective</td>\n<td>\n<ul>\n<li>Fatal, malfunction of several different organ systems</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Familial tumoral calcinosis (FTC)</td>\n<td>UDP-GalNAc transferase 3</td>\n<td>\n<ul>\n<li>Calcium deposits in skin and subcutaneous tissues</li>\n<li>Unresponsiveness to parathyroid hormone</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Walker–Warburg syndrome (WWS)</td>\n<td>Defective α-dystroglycan</td>\n<td>\n<ul>\n<li>Agenesis of corpus callosum</li>\n<li>Anal atresia</li>\n<li>Atresia of the external auditory canal</li>\n<li>Blindness</li>\n<li>Buphthalmos</li>\n<li>Cerebellar dysplasia</li>\n<li>Cleft upper lip</li>\n</ul>\n</td>\n</tr>\n<tr>\n<td>Hereditary erythroblastic multinuclearity with positive acidified serum lysis test (HEMPAS)</td>\n<td>Defects in alpha–mannosidase II</td>\n<td>\n<ul>\n<li>Ineffective erythropoiesis</li>\n<li>Haemolysis &amp; erythroblast morphological abnormalities</li>\n<li>Hypoglycosylation of some red blood cell (RBC) membrane proteins</li>\n</ul>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7354",
      "difficulty": "medium"
    },
    {
      "text": "Match the given conditions with their usual clinical presentation:<div class='question-desc-html'><table>\n<tbody>\n<tr>\n<td>1. Conn’s syndrome</td>\n<td>a. Nausea, vomiting, normal blood pressure, normal potassium, low BUN</td>\n</tr>\n<tr>\n<td>2. Cushing’s syndrome</td>\n<td>b. Nausea, vomiting, hypotension, hyperkalemia, high BUN</td>\n</tr>\n<tr>\n<td>3. Addison’s disease</td>\n<td>c. Fatigue, hypertension, low potassium, low renin</td>\n</tr>\n<tr>\n<td>4. SIADH</td>\n<td>d. Fatigue, hypertension, high sodium, high bicarbonate</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div></div>",
      "choices": [
        {
          "id": 1,
          "text": "1-c, 2-d, 3-b, 4-a"
        },
        {
          "id": 2,
          "text": "1-d, 2-c, 3-b, 4-a"
        },
        {
          "id": 3,
          "text": "1-b, 2-d, 3-a, 4-c"
        },
        {
          "id": 4,
          "text": "1-c, 2-b, 3-d, 4-a"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>The correct answer is <strong>1-c, 2-d, 3-b, 4-a.</strong> </p>\n<table>\n<tbody>\n<tr>\n<td>1. Conn’s syndrome</td>\n<td>c. Fatigue, hypertension, low potassium, low renin</td>\n</tr>\n<tr>\n<td>2. Cushing’s syndrome</td>\n<td>d. Fatigue, hypertension, high sodium, high bicarbonate</td>\n</tr>\n<tr>\n<td>3. Addison’s disease</td>\n<td>b. Nausea, vomiting, hypotension, hyperkalemia, high BUN</td>\n</tr>\n<tr>\n<td>4. SIADH</td>\n<td>a. Nausea, vomiting, normal blood pressure, normal potassium, low BUN</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Conn’s syndrome</strong> or <strong>primary hyperaldosteronism</strong>, is characterized by <strong>excessive production of aldosterone</strong>, which increases <strong>sodium reabsorption</strong> and<strong> potassium excretion</strong> in the kidneys. This results in <strong>hypertension, hypokalemia,</strong> fatigue due to electrolyte imbalance, and <strong>low renin</strong> levels due to feedback inhibition.</p>\n<p><strong>Cushing’s syndrome</strong> involves high levels of <strong>cortisol</strong>. This can lead to <strong>sodium retention, potassium loss, high bicarbonate, and altered glucose metabolism</strong>. This causes symptoms of <strong>hypertension, fatigue,</strong> and elevated blood glucose. </p>\n<p><strong>Addison’s disease</strong> is caused due to <strong>insufficient production of cortisol and aldosterone</strong>. The lack of cortisol causes <strong>reduced gluconeogenesis </strong>and <strong>increased ACTH secretion</strong>, which in turn leads to increased potassium levels. The lack of aldosterone causes<strong> reduced sodium reabsorption and increased potassium retention.</strong> This results in symptoms of <strong>hypotension, nausea, vomiting,</strong> and <strong>elevated BUN</strong> due to impaired renal function.</p>\n<p><strong>SIADH </strong>(syndrome of inappropriate ADH secretion) involves excessive secretion of ADH despite <strong>normal or low plasma osmolality.</strong> This causes <strong>water retention, diluting serum sodium, and increasing urine osmolality.</strong> The resultant fluid overload can cause <strong>nausea, vomiting, and low BUN.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6493",
      "difficulty": "medium"
    },
    {
      "text": "A 40-year-old woman undergoes an abdominal CT which incidentally reveals a 2 cm adrenal mass. Further tests show that it is non-functional. What is the most appropriate management for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Follow-up CT after 6 months"
        },
        {
          "id": 2,
          "text": "Medical therapy with spironolactone"
        },
        {
          "id": 3,
          "text": "Unilateral open adrenalectomy"
        },
        {
          "id": 4,
          "text": "Unilateral laparoscopic adrenalectomy"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In this patient with a <strong>2 cm non-functional adrenal</strong> <strong>mass</strong>, the most appropriate initial approach is <strong>conservative management</strong> with a <strong>follow-up CT after 6 months</strong> to monitor for any growth or changes in the adrenal mass.</p>\n<p>Adrenal incidentalomas are <strong>asymptomatic</strong> adrenal masses detected incidentally on imaging performed for other reasons. These can be benign or malignant<strong> </strong>tumors of <strong>adrenal or extra-adrenal</strong> <strong>origin</strong>. These tumors can be <strong>functioning </strong>(secreting excess hormones) or<strong> non-functioning</strong>.</p>\n<p>Management of an adrenal incidentaloma largely depends on its size and functional status. Incidentalomas which are <strong>small (&lt;3 cm)</strong>, <strong>benign, non-functioning tumors</strong> <strong>do not require immediate surgery</strong>. Instead, these patients should undergo a <strong>follow-up CT/MRI at 6 months</strong> to monitor for any changes or growth in the adrenal mass.</p>\n<p><strong>Adrenalectomy</strong> is indicated in <strong>all tumors &gt;4 cm</strong> <strong>functional tumors, </strong>tumors showing <strong>imaging </strong>characteristics of <strong>malignancy</strong> or <strong>significant</strong> <strong>growth</strong>.</p>\n<p>Other options: </p>\n<p>Option B: <strong>Medical therapy </strong>with <strong>spironolactone</strong> is not indicated for non-functional adrenal masses.</p>\n<p>Option C: <strong>Open adrenalectomy</strong> is suggested for unilateral adrenal masses that exhibit radiological signs of malignancy.</p>\n<p>Option D: <strong>Laparoscopic adrenalectomy</strong> is advised for unilateral <strong>adrenal masses &lt; 6 cm </strong>in diameter that show radiological features suggesting malignancy but lack signs of local invasion.</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG5401",
      "difficulty": "easy"
    },
    {
      "text": "A 45-year-old female presented with a history of fatigue. Examination findings are shown below. Which of the following is used to confirm the diagnosis?",
      "choices": [
        {
          "id": 1,
          "text": "ACTH stimulation test"
        },
        {
          "id": 2,
          "text": "Serum cortisol measurement"
        },
        {
          "id": 3,
          "text": "Low-dose dexamethasone suppression test"
        },
        {
          "id": 4,
          "text": "High-dose dexamethasone suppression test"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>In a patient presenting with <strong>fatigue</strong> and <strong>hyperpigmentation of the palms and the oral cavity (mucocutaneous hyperpigmentation)</strong>, a diagnosis of <strong>primary adrenal insufficiency</strong> <strong>(Addison's disease)</strong> is most likely. The <strong>test used to confirm</strong> the diagnosis of adrenal insufficiency is the <strong>ACTH stimulation test </strong>(also known as the <strong>short cosyntropin test</strong> or <strong>short Synacthen test</strong>).</p>\n<p><strong>ACTH stimulation test</strong> involves the <strong>administration of an exogenous, synthetic peptide</strong> that has an <strong>activity similar to ACTH</strong> on the adrenal glands. <strong>Serum cortisol</strong> levels are <strong>measured prior to, and after the administration</strong> of the synthetic peptide. <strong>Cortisol levels lower than the cut-off</strong> value indicate a <strong>failure of the adrenal glands to increase the production of cortisol</strong> in response to synthetic ACTH — thus <strong>confirming the diagnosis</strong> of adrenal insufficiency. Note that this will be <strong>seen in both primary and secondary</strong> adrenal insufficiency.</p>\n<p>Adrenal insufficiency can be divided into:</p>\n<p><strong>Primary adrenal insufficiency</strong> <strong>(Addison's disease)</strong> is most commonly due to <strong>autoimmune adrenalitis</strong>. These patients are likely to develop other autoimmune diseases such as vitiligo, premature ovarian failure, and autoimmune thyroid disease. Other causes of Addison's disease include <strong>destruction of the adrenal gland due to infections such as TB</strong>, <strong>hemorrhage</strong> (<strong>Waterhouse-Friderichsen syndrome</strong> due to meningococcemia) or <strong>infiltration</strong>.</p>\n<p><strong>Secondary adrenal insufficiency</strong> occurs due to hypothalamic-pituitary axis dysfunction. This can include <strong>iatrogenic suppression</strong> due to chronic therapy with glucocorticoids, or because of <strong>pituitary</strong> and <strong>hypothalamic</strong> <strong>tumors</strong>.<strong> Pituitary apoplexy</strong> because of hypovolemic shock during parturition <strong>(Sheehan syndrome)</strong> can also cause secondary adrenal insufficiency.</p>\n<p>The patients present with <strong>fatigue</strong> and <strong>loss of energy</strong>. Primary adrenal insufficiency causes <strong>hyperpigmentation due to excess ACTH</strong>, which stimulates the melanocytes to produce more pigment. Hyperpigmentation is <strong>maximally seen in areas exposed to sunlight</strong> or that which <strong>undergo friction</strong>. However, <strong>secondary adrenal insufficiency</strong> presents with<strong> skin paleness</strong> due to the complete absence of ACTH. </p>\n<p>The <strong>diagnosis</strong> of adrenal insufficiency is <strong>established by the ACTH stimulation test</strong> as described above. Primary and secondary adrenal insufficiencies can be differentiated biochemically:</p>\n<table>\n<tbody>\n<tr>\n<td><strong>Primary adrenal insufficiency</strong></td>\n<td><strong>Secondary adrenal insufficiency</strong></td>\n</tr>\n<tr>\n<td>Serum cortisol after ACTH stimulation: low</td>\n<td>Serum cortisol after ACTH stimulation: low</td>\n</tr>\n<tr>\n<td>Serum ACTH: <strong>high</strong></td>\n<td>Serum ACTH: <strong>low</strong></td>\n</tr>\n<tr>\n<td>Plasma renin: <strong>high</strong> (minerocorticoid deficiency also present, since adrenal gland itself is not functioning)</td>\n<td>Plasma renin: <strong>normal</strong> (adrenal gland itself is functional and can be regulated by renin-angiotensin system)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><br />Patients should also undergo screening for steroid autoantibodies and a CT scan of the adrenal glands to narrow down the cause of the adrenal insufficiency. </p>\n<p>Treatment is with <strong>oral hydrocortisone</strong> 15-25 mg/day in 2-3 divided doses. <strong>Long-acting agents are not preferred</strong> because they cause receptor activation even when the cortisol levels are supposed to be physiologically low in the body. Mineralocorticoid replacement is done with <strong>fludrocortisone</strong> 100-150 μg.</p><hr><h3>Related Pearl: Causes of Adrenocortical Insufficiency</h3><p><strong>Primary</strong><strong>&nbsp;adrenal insufficiency:</strong></p>\n<ul>\n<li>Anatomical destruction of gland</li>\n<li>Autoimmune (Addison's disease)</li>\n<li>Isolated autoimmune adrenalitis (polygenic)</li>\n<li>Infections -&nbsp;HIV, tuberculosis, fungi</li>\n<li>Surgical removal</li>\n<li>Acute hemorrhagic necrosis (Waterhouse-Friderichsen syndrome)</li>\n<li>Amyloidosis, sarcoidosis, hemochromatosis</li>\n<li>Metastatic carcinoma</li>\n<li>Cytotoxic agents &ndash; mitotane</li>\n<li>Enzyme inhibitors &ndash; metyrapone, ketoconazole</li>\n<li>Congenital adrenal hypoplasia</li>\n<li>Autoimmune polyendocrinopathy syndrome type 1 (AIRE1 gene on 21q22)</li>\n<li>Autoimmune polyendocrinopathy syndrome type 2 (polygenic)</li>\n<li>X-linked adrenal hypoplasia (DAX1 gene on Xp21)</li>\n<li>Adrenoleukodystrophy (ALD gene on Xq28)</li>\n</ul>\n<p><strong>Secondary adrenal insufficiency:</strong></p>\n<p>Hypopituitarism due to hypothalamic or pituitary disease</p>\n<ul>\n<li>Neoplasm</li>\n<li>Infiltration (sarcoidosis)</li>\n<li>Infection (tuberculosis, pyogenic, fungal)</li>\n</ul>\n<p>Suppression of HPA axis</p>\n<ul>\n<li>By endogenous steroids from tumor</li>\n<li>By exogenous steroids</li>\n</ul>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/5fb4f3c9766d4c708438d2c5aa11f3d5.PNG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9493",
      "difficulty": "hard"
    },
    {
      "text": "A patient with a history of fatigue and lethargy is being evaluated for adrenal insufficiency. The diagnosis was confirmed using a cosyntropin stimulation test, and subsequent testing revealed low morning ACTH levels. What is the next best diagnostic test for this patient?\n",
      "choices": [
        {
          "id": 1,
          "text": "Adrenal autoantibodies"
        },
        {
          "id": 2,
          "text": "Adrenal CT"
        },
        {
          "id": 3,
          "text": "MRI pituitary"
        },
        {
          "id": 4,
          "text": "Chest X-ray"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This patient with adrenal insufficiency has <strong>low ACTH levels</strong> suggestive of <strong>secondary adrenal insufficiency</strong>. Thus, the next best test would be an<strong> MRI pituitary.</strong></p>\n<p>Secondary adrenal insufficiency results from defects in <strong>ACTH secretion</strong> by the<strong> pituitary</strong> gland or <strong>CRH secretion</strong> by the <strong>hypothalamus</strong>. In this context, an <strong>MRI of the pituitary</strong> is the most appropriate next step.</p>\n<p><strong>Adrenal insufficiency</strong> is the decreased production of adrenocortical hormones and is classified as <strong>primary</strong>, or <strong>secondary</strong>. Evaluation of adrenal insufficiency begins with <strong>clinical suspicion</strong> based on symptoms such as <strong>weight loss</strong>, <strong>fatigue,</strong> <strong>postural hypotension</strong>, <strong>hyperpigmentation</strong>, and <strong>hyponatremia</strong>.</p>\n<p><strong>Diagnosis </strong>is confirmed with a <strong>cosyntropin stimulation test</strong>, which measures the adrenal glands' response to <strong>synthetic ACTH (cosyntropin)</strong>. A baseline cortisol level is obtained, followed by cosyntropin administration, with cortisol levels measured again after 30-60 minutes. In adrenal insufficiency, cortisol levels remain low despite stimulation.</p>\n<p>Differentiation between<strong> primary </strong>and <strong>secondary</strong> causes involves measuring <strong>plasma ACTH levels</strong>. <strong>High ACTH levels</strong> indicate<strong> primary adrenal insufficiency</strong>, warranting <strong>adrenal autoantibody tests</strong> and further <strong>imaging </strong>like chest X-ray or adrenal CT to determine the cause. <strong>Low or normal ACTH </strong>levels indicate <strong>secondary adrenal insufficiency</strong>, necessitating an <strong>MRI of the pituitary</strong> to identify possible lesions or other underlying causes (in patients not taking corticosteroids). </p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/fb5cb8423cd7445f90ae0986a246a898x1200x2468.JPEG\" alt=\"Explanation Image\"><p>Other options</p>\n<p>Option A: <strong>Adrenal autoantibodies</strong> are used to diagnose<strong> autoimmune adrenalitis</strong>, which is a cause of <strong>primary adrenal insufficiency</strong>. However, the patient's response to cosyntropin indicates<strong> secondary adrenal insufficiency</strong>.</p>\n<p>Option B: <strong>Imaging </strong>of the<strong> adrenal glands </strong>is useful in cases of <strong>primary adrenal insufficiency</strong> to detect structural abnormalities. Since the patient likely has <strong>secondary adrenal insufficiency</strong>, this option is not the most immediate next step.</p>\n<p>Option D: A <strong>chest X-ray </strong>might be used if there is suspicion of <strong>tuberculosis </strong>affecting the adrenal glands, but there is no indication in this patient. </p><hr><h3>Related Pearl: Causes of Adrenocortical Insufficiency</h3><p><strong>Primary</strong><strong>&nbsp;adrenal insufficiency:</strong></p>\n<ul>\n<li>Anatomical destruction of gland</li>\n<li>Autoimmune (Addison's disease)</li>\n<li>Isolated autoimmune adrenalitis (polygenic)</li>\n<li>Infections -&nbsp;HIV, tuberculosis, fungi</li>\n<li>Surgical removal</li>\n<li>Acute hemorrhagic necrosis (Waterhouse-Friderichsen syndrome)</li>\n<li>Amyloidosis, sarcoidosis, hemochromatosis</li>\n<li>Metastatic carcinoma</li>\n<li>Cytotoxic agents &ndash; mitotane</li>\n<li>Enzyme inhibitors &ndash; metyrapone, ketoconazole</li>\n<li>Congenital adrenal hypoplasia</li>\n<li>Autoimmune polyendocrinopathy syndrome type 1 (AIRE1 gene on 21q22)</li>\n<li>Autoimmune polyendocrinopathy syndrome type 2 (polygenic)</li>\n<li>X-linked adrenal hypoplasia (DAX1 gene on Xp21)</li>\n<li>Adrenoleukodystrophy (ALD gene on Xq28)</li>\n</ul>\n<p><strong>Secondary adrenal insufficiency:</strong></p>\n<p>Hypopituitarism due to hypothalamic or pituitary disease</p>\n<ul>\n<li>Neoplasm</li>\n<li>Infiltration (sarcoidosis)</li>\n<li>Infection (tuberculosis, pyogenic, fungal)</li>\n</ul>\n<p>Suppression of HPA axis</p>\n<ul>\n<li>By endogenous steroids from tumor</li>\n<li>By exogenous steroids</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6485",
      "difficulty": "medium"
    },
    {
      "text": "Which of the following statements are true regarding pheochromocytoma?<div class='question-desc-html'><ol>\n<li>Associated with sustained hypertension</li>\n<li>Associated with paroxysmal hypertension</li>\n<li>Associated with orthostatic hypotension</li>\n<li>Most are bilateral</li>\n<li>DOPA-PET scan can be done for localization</li>\n</ol></div>",
      "choices": [
        {
          "id": 1,
          "text": "2, 3"
        },
        {
          "id": 2,
          "text": "1, 2, 3, 5"
        },
        {
          "id": 3,
          "text": "2, 4"
        },
        {
          "id": 4,
          "text": "1, 3, 5"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p><strong>Pheochromocytoma</strong> can present with both <strong>paroxysmal</strong> <strong>and sustained hypertension</strong>, and<strong> DOPA-PET can be used for the localization</strong> of the tumor.</p>\n<p><strong>Pheochromocytomas</strong> and <strong>paragangliomas</strong> are <strong>catecholamine-producing tumors</strong> that are <strong>derived from the autonomic nervous system</strong>. According to WHO terminology, the term <strong>pheochromocytoma</strong> is restricted to <strong>adrenal tumors</strong>, while the term <strong>paraganglioma</strong> is used for <strong>all the other sites</strong>.</p>\n<p>The patients present with the <strong>classic triad of headache</strong>, <strong>sweating</strong>, and <strong>palpitations</strong>. The dominant finding seen in the patients is <strong>hypertension</strong>. <strong>Both</strong> <strong>episodic/paroxysmal and sustained hypertension</strong> can be seen in the patients. During one of these episodes, there can be arrhythmias and heart failure. Pheochromocytoma is a state of <strong>contraction of the intravascular volume</strong>. This is because <strong>increased catecholamines</strong> cause <strong>systemic vasoconstriction</strong>. Further, there is<strong> increased activity of the renin-angiotensin-aldosterone system</strong>, causing <strong>efferent arteriolar vasoconstriction and increased filtration</strong> in the kidneys. Intravascular volume contraction causes <strong>orthostatic hypotension</strong>. </p>\n<p><strong>Biochemical tests</strong> used to diagnose pheochromocytoma include <strong>24-hour urinary</strong> catecholamines and metanephrines, <strong>and</strong> <strong>plasma</strong> <strong>catecholamines and metanephrines</strong>. <strong>T2 weighted MRI with gadolinium contrast</strong> is the investigation of choice <strong>for localization</strong> of the tumor. This is better than contrast-enhanced CT for detecting extra-adrenal tumors. <strong>Localization</strong> can <strong>also </strong>be done<strong> using</strong> <strong>MIBG</strong> and <strong>DOPA-PET scan</strong>. These agents are also useful for <strong>assessing metastatic disease</strong>.</p>\n<p>The optimal<strong> treatment is by resection of the tumor</strong>, either by <strong>partial or complete adrenelectomy</strong>. Normal adrenal cortex preservation is important to prevent the development of Addison's disease when the tumor is present bilaterally. The <strong>pre-operative preparation</strong> consists of giving <strong>oral phenoxybenzamine for α blockade first</strong>. Oral prazosin or IV phentolamine can be given to the patient while adequate α blockade with phenoxybenzamine is awaited. α blockade is achieved first in patients with pheochromocytoma because <strong>β blockade alone will cause severe vasoconstriction</strong> because of the elevated catecholamine levels. <strong>Once α blockade</strong> is <strong>achieved,</strong> <strong>β blockers</strong> are then <strong>added</strong>.</p><hr><h3>Related Pearl: Clinical features of Pheochromocytoma (By frequency of occurrence)</h3><ul>\n<li>Classical triad of symptoms:\n<ul>\n<li>Headaches &ndash; most common symptom</li>\n<li>Profuse sweating</li>\n<li>Palpitations and tachycardia</li>\n</ul>\n</li>\n<li>Hypertension (sustained or intermittent) &ndash; most common&nbsp;sign</li>\n<li>Anxiety,&nbsp;panic attacks</li>\n<li>Hyperglycemia</li>\n<li>Hypercalcemia</li>\n<li>Pallor - due to&nbsp;alpha-1 mediated vasoconstriction</li>\n<li>Polyuria and polydipsia&nbsp;</li>\n<li>Orthostatic hypotension</li>\n<li>Dilated cardiomyopathy</li>\n<li>Erythrocytosis, high hematocrit (hemoconcentration)</li>\n<li>Constipation</li>\n<li>Abdominal pain</li>\n<li>Weakness</li>\n<li>Weight loss</li>\n<li>Nausea</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF3095",
      "difficulty": "hard"
    },
    {
      "text": "Which of the following is not a feature of 11-beta-hydroxylase deficiency?",
      "choices": [
        {
          "id": 1,
          "text": "Metabolic acidosis"
        },
        {
          "id": 2,
          "text": "Hypokalemia"
        },
        {
          "id": 3,
          "text": "Hypertension"
        },
        {
          "id": 4,
          "text": "Virilization"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p><strong>11-beta-hydroxylase deficiency</strong>&nbsp;is associated with<strong>&nbsp;metabolic alkalosis</strong>, not metabolic acidosis.</p>\n<p>It is a rare form of congenital adrenal hyperplasia that presents with the following features:</p>\n<ul>\n<li>Glucocorticoid deficiency:\n<ul>\n<li>Hypoglycemia</li>\n<li>Hyperpigmentation around the genitals due to excess adrenocorticotropic hormone (ACTH) secretion&nbsp;</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Mineralocorticoid excess:\n<ul>\n<li><strong>Hypokalemia</strong></li>\n<li><strong>Hypertension</strong></li>\n<li>Metabolic alkalosis</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li>Adrenal androgen excess\n<ul>\n<li><strong>Virilization</strong> in females</li>\n<li>Precocious puberty in males</li>\n</ul>\n</li>\n</ul><hr><h3>Related Pearl: Variants of Congenital Adrenal Hyperplasia (CAH)</h3><table>\n<tbody>\n<tr>\n<td><strong>21-hydroxylase deficiency</strong></td>\n<td><strong>17-hydroxylase deficiency</strong></td>\n<td><strong>11&beta;-hydroxylase deficiency</strong></td>\n<td><strong>3&beta;-HSD deficiency</strong></td>\n</tr>\n<tr>\n<td>\n<p>Deficiency of cortisol and aldosterone</p>\n</td>\n<td>\n<p>Deficiency of cortisol and sex hormones</p>\n</td>\n<td>\n<p>Deficiency of cortisol</p>\n</td>\n<td>\n<p>Deficiency of cortisol, aldosterone, and testosterone</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>&uarr; in testosterone</p>\n</td>\n<td>&uarr; in aldosterone</td>\n<td>&uarr; in deoxycorticosterone (mineralocorticoid) and testosterone&nbsp;</td>\n<td>&uarr; in DHEA</td>\n</tr>\n<tr>\n<td>Salt wasting crises</td>\n<td>Salt retention and&nbsp; hypertension</td>\n<td>\n<p>Salt retention and&nbsp; hypertension</p>\n</td>\n<td>Salt-wasting crises</td>\n</tr>\n<tr>\n<td>Virilization of females (ambiguous genitalia 46XX) &nbsp;&nbsp;&nbsp;</td>\n<td>Failure of sexual development in females at puberty</td>\n<td>Virilization of females&nbsp; (ambiguous genitalia 46XX)</td>\n<td>Females are mildly<br /> virilized (DHEA is a weak androgen)</td>\n</tr>\n<tr>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n<td>Precocious puberty in males</td>\n<td>Males are incompletely virilized (ambiguous genitalia 46XY)</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p><strong>Note</strong>: In&nbsp;11&beta;-hydroxylase deficiency, aldosterone synthetic capacity is normal and some corticosterone is synthesized from progesterone by intact aldosterone synthase enzyme. Thus, it is unusual for patients to manifest signs of adrenal insufficiency.</p>\n<p>&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6942",
      "difficulty": "medium"
    },
    {
      "text": "The following changes were observed on the administration of a drug. Which of the following is the likely drug?",
      "choices": [
        {
          "id": 1,
          "text": "Epinephrine"
        },
        {
          "id": 2,
          "text": "Norepinephrine"
        },
        {
          "id": 3,
          "text": "Propranolol"
        },
        {
          "id": 4,
          "text": "Isoproterenol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>Since the administration of the given drug shows an <strong>increase in systolic, diastolic, and mean arterial pressure</strong>, along with <strong>reflex bradycardia</strong>, the drug is likely to be <strong>norepinephrine</strong>.</p>\n<p><strong>Norepinephrine</strong> acts on <strong>α<sub>1</sub> </strong>and<strong> β<sub>1</sub> receptors</strong> to increase the <strong>peripheral vascular resistance</strong> and <strong>stroke volume</strong> respectively. This causes an <strong>increase </strong>in<strong> diastolic, systolic, </strong>and<strong> mean arterial pressure</strong>. Increased mean arterial pressure leads to <strong>reflex bradycardia</strong>.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/475c8edb8a074b809384fa8fcaacdfd5x1280x1988.JPEG\" alt=\"Explanation Image\"><p><strong><br />Epinephrine</strong> (option A) acts on<strong> α<sub>1</sub>, β<sub>1,</sub> </strong>and<strong> β<sub>2</sub> receptors</strong>. There is a <strong>rise</strong> in <strong>systolic</strong> <strong>BP</strong>, but a <strong>fall</strong> in the <strong>diastolic</strong> <strong>BP </strong>— <strong>vascular β<sub>2</sub> receptors are more sensitive</strong> than α<sub>1</sub> receptors, leading to vasodilation. There is generally a <strong>small</strong> <strong>rise</strong> in the <strong>mean</strong> <strong>arterial</strong> <strong>pressure</strong>. The <strong>heart rate increases</strong> due to β<sub>1</sub> action.</p>\n<p><strong>Isoproterenol</strong> (option D) acts on <strong>β receptors</strong>, causing predominantly <strong>β<sub>2</sub> mediated vasodilation</strong> and resultant <strong>reflex tachycardia</strong>.</p>\n<p><strong>Propranolol</strong> (option C) is a <strong>β-blocker</strong> and will cause a <strong>decrease</strong> in the <strong>BP</strong> and <strong>heart rate</strong>.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/167cc0209d68468b9f26c06d1e2b22c5.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9378",
      "difficulty": "medium"
    },
    {
      "text": "Which among the following is the most sensitive test to distinguish between Cushing’s disease from ectopic ACTH production?\n",
      "choices": [
        {
          "id": 1,
          "text": "MRI pituitary"
        },
        {
          "id": 2,
          "text": "Inferior petrosal sinus sampling"
        },
        {
          "id": 3,
          "text": "High dose dexamethasone suppression test"
        },
        {
          "id": 4,
          "text": "CRH stimulation test"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The best test to differentiate <strong>Cushing’s disease</strong> from<strong> Ectopic ACTH</strong> production is <strong>Inferior petrosal sinus sampling </strong>(IPSS) owing to its high sensitivity (95%) and specificity (99%). </p>\n<p>During <strong>IPSS</strong>, catheters are placed in the <strong>inferior petrosal sinuses</strong>, which drain blood directly from the pituitary gland. Blood samples are collected from these sinuses and from a <strong>peripheral vein</strong> to measure ACTH levels.</p>\n<p>The principle of IPSS is based on the anatomical and functional characteristics of the pituitary gland:</p>\n<p><strong>Central-to-Peripheral Gradient:</strong> The <strong>pituitary </strong>gland directly releases ACTH into the venous blood that drains through the <strong>inferior petrosal sinuses.</strong> Therefore, in cases of<strong> Cushing's disease</strong> (where the source of excess ACTH is a pituitary adenoma), ACTH levels will be significantly higher in the blood samples taken from the <strong>inferior petrosal sinuses</strong> compared to the <strong>peripheral blood</strong>.</p>\n<p><strong>Baseline Ratio:</strong> A central-to-peripheral <strong>ACTH ratio greater than 2</strong> at baseline indicates the <strong>pituitary</strong> is the <strong>primary source </strong>of excess ACTH rather than from an ectopic source.</p>\n<p><strong>Stimulated Ratio:</strong> After the administration of CRH (corticotropin-releasing hormone), which stimulates ACTH secretion by the pituitary gland, a central-to-peripheral <strong>ACTH ratio greater than 3</strong> further confirms a <strong>pituitary source</strong>. This is because CRH administration would cause a more pronounced increase in ACTH release from a pituitary adenoma compared to ectopic sources.</p>\n<p>The absence of such a gradient (a ratio less than the thresholds mentioned) suggests that the source of excess ACTH is not the pituitary gland, but rather an <strong>ectopic source</strong> elsewhere in the body.</p>\n<p>MRI pituitary is not sensitive enough to detect small pituitary ACTH-secreting adenomas (&lt;2 mm).</p><hr><h3>Related Pearl: Causes of Cushing's Syndrome</h3><p><strong>Exogenous causes </strong>(iatrogenic)</p>\n<ul>\n<li>Prolonged administration of glucocorticoids (most common cause of Cushing's)</li>\n</ul>\n<p><strong>Endogenous causes</strong></p>\n<ul>\n<li><strong>ACTH independent </strong>(primary hypercortisolism)\n<ul>\n<li>Adrenocortical adenoma&nbsp;</li>\n<li>Adrenocortical carcinoma&nbsp;</li>\n<li>Bilateral adrenal hyperplasia</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>ACTH dependent&nbsp;</strong>(secondary hypercortisolism)\n<ul>\n<li><strong>Cushing&rsquo;s disease:&nbsp;</strong>ACTH secreting&nbsp;<strong>pituitary adenoma </strong>(most common cause of endogenous Cushing's)</li>\n<li><strong>Paraneoplastic causes: </strong>Ectopic ACTH secreting tumors\n<ul>\n<li><strong>Small-cell lung carcinoma</strong></li>\n<li>Bronchial or pancreatic carcinoid tumors</li>\n<li>Medullary thyroid carcinoma</li>\n<li>Pheochromocytoma</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Rare causes</strong></p>\n<ul>\n<li>Macronodular adrenal hyperplasia</li>\n<li>Primary pigmented nodular adrenal disease</li>\n<li>McCune <strong>&ndash;</strong> Albright syndrome</li>\n</ul><hr><h3>Related Pearl: Initial Tests for Diagnosing Cushing's Syndrome</h3><p>These include two steps:</p>\n<p><strong>1. Tests to detect hypercortisolism</strong></p>\n<ul>\n<li><strong>Midnight salivary or serum cortisol</strong> (highly sensitive test):<strong>&nbsp;</strong>The presence of cortisol in the saliva or serum at midnight signifies loss of diurnal variation of cortisol</li>\n<li><strong>24-hour urinary free cortisol excretion</strong>:&nbsp;Increased three times the normal value</li>\n<li><strong>Overnight dexamethasone suppression test</strong> (DST):&nbsp;Plasma cortisol &gt;1.8 &mu;g/dL at 8 a.m after overnight exposure to dexamethasone (1 mg given at 11 p.m)</li>\n<li><strong>Low dose DST</strong> (highly specific test):&nbsp;Plasma cortisol &gt;1.8 &mu;g/dL at 8 a.m. on the third day after giving 0.5 mg dexamethasone every 6 hours for 2 days</li>\n</ul>\n<p><strong>2. Test </strong><strong>to rule out pseudo Cushing's syndrome</strong></p>\n<ul>\n<li><strong>Low-dose DST + CRH stimulation test</strong>: Plasma cortisol levels are increased in true Cushing&rsquo;s but remain unaffected in pseudo Cushing's.&nbsp;Dexa-induced negative feedback is overcome by CRH in true Cushing&rsquo;s.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6484",
      "difficulty": "hard"
    },
    {
      "text": "Shown below is a section taken from a specimen of an adrenal gland. Which of the following results in a decrease in the hormone exclusively secreted by the layer marked as '1'?",
      "choices": [
        {
          "id": 1,
          "text": "Hyperkalemia"
        },
        {
          "id": 2,
          "text": "ACTH"
        },
        {
          "id": 3,
          "text": "Renin"
        },
        {
          "id": 4,
          "text": "Hypernatremia"
        }
      ],
      "correct_choice_id": 4,
      "solution": "<div class=\"page\" title=\"Page 926\">\n<div class=\"section\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p>In the above image, the layer marked as '1' is <strong>zona glomerulosa, </strong>and <strong>aldosterone </strong>is exclusively secreted by this layer. <strong>Hypernatremia </strong>decreases<strong> aldosterone secretion</strong>. </p>\n<p>The <strong>zona glomerulosa </strong>is a thin layer of cells that lies just underneath the capsule of<strong> </strong>the<strong> adrenal gland.</strong></p>\n<p>The following factors are known to play roles in the regulation of aldosterone: </p>\n<ul>\n<li><strong>Hyperkalemi</strong><strong>a increases</strong> aldosterone secretion.</li>\n<li><strong>Increased angiotensin II</strong> concentration <strong>increases</strong> aldosterone secretion.</li>\n<li><strong>Hypernatremia </strong>concentration in the extracellular fluid<strong> slightly decreases </strong>aldosterone secretion.</li>\n<li><strong>ACTH</strong> from the anterior pituitary gland is necessary for aldosterone secretion but has <strong>minimal effect</strong> in physiological conditions.</li>\n<li>Increased sodium ion concentration in the extracellular fluid decreases aldosterone secretion.</li>\n</ul>\n<p>Other options:</p>\n<p>The adrenal cortex has three zones. From outer to inner, they are:</p>\n<ul>\n<li>Zona glomerulosa: Secretes mineralocorticoids (Aldosterone)</li>\n<li>Zona fasiculata: Secretes glucocorticoids (Cortisol)</li>\n<li>Zona reticularis: Secretes sex steroids</li>\n</ul>\n<p>The adrenal medulla secretes catecholamines. </p>\n</div>\n</div>\n</div>\n</div><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/5f8f678ebee14a4c898fd7b400c9c2afx1279x984.JPEG\" alt=\"Explanation Image\">",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/45e4c35bf17942a59b1d207bb2617e5e.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD4859",
      "difficulty": "medium"
    },
    {
      "text": "CRH responsiveness and residual ACTH suppression by high-dose dexamethasone are seen in hypercortisolism due to:",
      "choices": [
        {
          "id": 1,
          "text": "Pituitary adenoma"
        },
        {
          "id": 2,
          "text": "ACTH dependent adrenal tumor"
        },
        {
          "id": 3,
          "text": "Small cell lung cancer"
        },
        {
          "id": 4,
          "text": "ACTH independent adrenal tumor"
        }
      ],
      "correct_choice_id": 1,
      "solution": "<p>CRH responsiveness is seen only in hypercortisolism which is due to a pituitary cause.</p>\n<p>Physiologically, CRH released from the hypothalamus has a stimulatory effect on the pituitary corticotropic cells, thus producing ACTH.</p>\n<p>Hypercortisolism may be <strong>endogenous </strong>or <strong>iatrogenic</strong>.</p>\n<ul>\n<li>Iatrogenic hypercortisolism is not affected by dynamic testing</li>\n<li>Endogenous hypercortisolism may be ACTH-dependent or ACTH-independent</li>\n</ul>\n<p>ACTH-dependent Cushing&rsquo;s syndrome can be further classified by dynamic testing:</p>\n<p>Pituitary cause:</p>\n<ul>\n<li>CRH test &ndash; Positive. ACTH increase &gt; 40% at 15&ndash;30 min + cortisol increase &gt;20% at 45&ndash;60 min after CRH 100 &mu;g IV</li>\n<li>High-dose dexamethasone suppression test - Positive. Cortisol suppression &gt;50% after q6h 2 mg dexamethasone administration for 2 days</li>\n</ul>\n<p>Ectopic cause:</p>\n<ul>\n<li>CRH test - Negative</li>\n<li>High-dose dexamethasone suppression test - Negative</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC9963",
      "difficulty": "hard"
    },
    {
      "text": "A 50-year-old female is suspected to have Cushing's syndrome. Which of the following investigations is not performed until a confirmatory diagnosis of Cushing's syndrome is established?",
      "choices": [
        {
          "id": 1,
          "text": "Estimation of midnight salivary cortisol"
        },
        {
          "id": 2,
          "text": "High dose dexamethasone suppression test"
        },
        {
          "id": 3,
          "text": "Low dose dexamethasone suppression test"
        },
        {
          "id": 4,
          "text": "Measurement of 24 hours urinary free cortisol"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The <strong>high-dose dexamethasone suppression test</strong> is done only <strong>after a diagnosis</strong> of Cushing's syndrome is established in a patient.</p>\n<p>The high-dose dexamethasone suppression test is used in patients with confirmed Cushing syndrome. It helps to <strong>differentiate between Cushing's disease (i.e a pituitary cause) and ectopic ACTH production</strong>.</p>\n<p>The basis for this test is that in subjects with Cushing disease, a <strong>higher dose of dexamethasone</strong> (usually 8 mg) is <strong>required to suppress ACTH </strong>secretion and drop cortisol levels in serum, urine, and saliva.</p>\n<p><strong>Standard 2-day (high dose) dexamethasone suppression test:</strong></p>\n<ul>\n<li><strong>Serum cortisol level</strong> and/or 24-hour <strong>urinary free cortisol i</strong>s measured as a baseline, and then dexamethasone <strong>2 mg</strong> orally is taken <strong>every 6 hours</strong> for 48 hours; urine for free cortisol is collected during the test, and serum cortisol is checked <strong>6 hours after the last dose</strong>. The <strong>suppression</strong> of cortisol secretion to <strong>&gt;50 % of the baseline</strong> is considered positive and indicative of Cushing's disease</li>\n</ul>\n<p>The following four investigations are used to establish an initial diagnosis of endogenous Cushing's syndrome as per the clinical guidelines of the endocrine society.</p>\n<ul>\n<li><strong>24-hour urinary free cortisol</strong> (increased 3x above normal)</li>\n<li><strong>Midnight salivary cortisol</strong> ( &gt;5nmol/L)</li>\n<li>Overnight dexamethasone suppression (plasma cortisol &gt;50 nmol/L at 8-9 AM after 1 mg dexamethasone at 11 PM)</li>\n<li>Standard 2-day <strong>(low dose)</strong> <strong>dexamethasone suppression test</strong> (plasma cortisol &gt; 50 nmol/L after <strong>0.5 mg</strong> dexamethasone 6th hourly for 48 hours).</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD3541",
      "difficulty": "easy"
    },
    {
      "text": "A 70-year-old man is brought to the emergency department with altered mental status. Lab workup shows serum sodium of 110 mEq/L and negative alcohol and toxicology screens. An opacity in the left lower lung is seen on the chest X-Ray. What is the management of this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Fluid restriction"
        },
        {
          "id": 2,
          "text": "Demeclocycline"
        },
        {
          "id": 3,
          "text": "3% saline"
        },
        {
          "id": 4,
          "text": "Conivaptan"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The given clinical scenario is suggestive of&nbsp;<strong>syndrome of inappropriate antidiuretic hormone&nbsp;</strong>(SIADH) with&nbsp;<strong>altered mental status</strong>, and the management in this patient is&nbsp;<strong>3% saline</strong>.</p>\n<p>SIADH occurs due to <strong>excessive production</strong> of <strong>ADH</strong> (or vasopressin). The most common cause are neuroendocrine neoplasms like <strong>small cell lung carcinoma</strong>&nbsp;(at least half the cases) and carcinoids.</p>\n<p>Symptoms include decreased thirst, lethargy, nausea, confusion, depressed mental status, and seizures. However, most patients are asymptomatic and are diagnosed incidentally due to the presence of <strong>hyponatremia</strong>. The severity of symptoms indicates the severity of hyponatremia. Hyponatremia occurs with <strong>decreased serum osmolality</strong> and <strong>normal</strong> or <strong>increased urine osmolality</strong>.</p>\n<p>Management includes <strong>correction of hyponatremia</strong> and treatment of the underlying malignancy. Since hyponatremia develops over several weeks to months, it should be corrected <strong>gradually</strong> at a rate of 0.5&ndash;1 meq/L/h to prevent brain dehydration and central pontine myelinolysis (an acute life-threatening neurological syndrome characterized by quadriparesis, ataxia, and abnormal extraocular movements).</p>\n<ul>\n<li><strong>Hypervolemic hyponatremia</strong>:\n<ul>\n<li><strong>Fluid restriction</strong> to less than urine output, plus insensible losses, with strict monitoring of fluid intake in mild cases</li>\n<li><strong>Vasopressin receptor antagonists</strong>, like conivaptan and tolvaptan, in severe cases</li>\n</ul>\n</li>\n<li><strong>Hypovolemic hyponatremia</strong> and/or <strong>altered mental status&nbsp;</strong>(indicating severe hyponatremia of &lt;115 mEq/L): <strong>Hypertonic (3%) </strong>or <strong>isotonic saline</strong> infusion</li>\n</ul>\n<p><strong>Demeclocycline</strong>, an inhibitor of vasopressin, is not preferred due to its relatively <strong>slower onset</strong> of action (1&ndash;2 weeks).</p><hr><h3>Related Pearl: Causes of SIADH</h3><p><strong>Neoplasms</strong></p>\n<p><strong>Carcinomas</strong></p>\n<ul>\n<li>Lung</li>\n<li>Duodenum</li>\n<li>Pancreas</li>\n<li>Ovary</li>\n<li>Bladder, ureter</li>\n</ul>\n<p><strong>Other neoplasms</strong></p>\n<ul>\n<li>Thymoma</li>\n<li>Mesothelioma</li>\n<li>Bronchial adenoma</li>\n<li>Carcinoid</li>\n<li>Gangliocytoma</li>\n<li>Ewing&rsquo;s sarcoma</li>\n</ul>\n<p><strong>Head trauma</strong> (closed and penetrating)</p>\n<p><strong>Infections</strong></p>\n<ul>\n<li>Pneumonia</li>\n<li>Abscess</li>\n<li>Cavitation (aspergillosis)</li>\n<li>Tuberculosis</li>\n<li>Meningitis, Encephalitis</li>\n<li>AIDS</li>\n</ul>\n<p><strong>Vascular</strong></p>\n<ul>\n<li>Cerebrovascular occlusions, haemorrhage</li>\n<li>Cavernous sinus thrombosis</li>\n</ul>\n<p><strong>Neurologic</strong></p>\n<ul>\n<li>Guillain-Barre syndrome</li>\n<li>Multiple sclerosis</li>\n<li>Delirium tremens</li>\n<li>Amyotrophic lateral sclerosis</li>\n<li>Hydrocephalus</li>\n<li>Psychosis</li>\n<li>Peripheral neuropathy</li>\n</ul>\n<p><strong>Congenital malformations</strong></p>\n<p><strong>Metabolic</strong></p>\n<ul>\n<li>Acute intermittent porphyria</li>\n</ul>\n<p><strong>Respiratory</strong></p>\n<ul>\n<li>Asthma</li>\n<li>Pneumothorax</li>\n<li>Positive-pressure respiration</li>\n</ul>\n<p><strong>Drugs</strong></p>\n<ul>\n<li>Vasopressin or desmopressin</li>\n<li>Serotonin reuptake inhibitors</li>\n<li>Oxytocin (high dose)</li>\n<li>Vincristine</li>\n<li>Carbamazepine</li>\n<li>Nicotine</li>\n<li>Phenothiazines</li>\n<li>Cyclophosphamide</li>\n<li>Tricyclic antidepressants</li>\n<li>Monoamine oxidase inhibitors</li>\n</ul><hr><h3>Related Pearl: Distribution of body fluids</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Type</strong></p>\n</td>\n<td>\n<p><strong>Example</strong></p>\n</td>\n<td>\n<p><strong>ECF volume</strong></p>\n</td>\n<td>\n<p><strong>ICF volume</strong></p>\n</td>\n<td>\n<p><strong>Osmolarity</strong></p>\n</td>\n<td>\n<p><strong>Hematocrit</strong></p>\n</td>\n<td>\n<p><strong>Plasma proteins</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isosmotic volume contraction</p>\n</td>\n<td>\n<p>Diarrhea,</p>\n<p>Burns</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperosmotic volume contraction</p>\n</td>\n<td>\n<p>Sweating,</p>\n<p>Fever,</p>\n<p>Diabetes insipidus</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyposmotic volume contraction</p>\n</td>\n<td>\n<p>Adrenal insufficiency</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Isosmotic volume expansion</p>\n</td>\n<td>\n<p>Infusion of isotonic NaCl</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyperosmotic volume expansion</p>\n</td>\n<td>\n<p>High NaCl intake</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hyposmotic volume expansion</p>\n</td>\n<td>\n<p>SIADH</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↑</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n<td>\n<p>No change</p>\n</td>\n<td>\n<p>↓</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div><hr><h3>Related Pearl: Paraneoplastic Syndromes and Underlying Cancers</h3><table>\n<tbody>\n<tr>\n<td>\n<p><strong>Clinical Syndromes/&nbsp;</strong></p>\n<p><strong>Endocrinopathies</strong></p>\n</td>\n<td>\n<p><strong>Major Forms of Underlying Cancer</strong></p>\n</td>\n<td>\n<p><strong>Causal Mechanism</strong></p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Cushing Syndrome</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Pancreatic carcinoma</p>\n<p>Neural tumours</p>\n<p>Renal carcinoma</p>\n</td>\n<td>\n<p>ACTH or ACTH- like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Syndrome of inappropriate antidiuretic hormone secretion (SIADH)</p>\n</td>\n<td>\n<p>Small-cell carcinoma of lung</p>\n<p>Intracranial neoplasms</p>\n</td>\n<td>\n<p>Antidiuretic hormone or atrial natriuretic hormones</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypercalcemia</p>\n</td>\n<td>\n<p>Squamous cell carcinoma of lung</p>\n<p>Breast carcinoma</p>\n<p>Renal carcinoma</p>\n<p>Adult T-cell leukemia/lymphoma</p>\n</td>\n<td>\n<p>Parathyroid hormone-related protein(PTHRP), TGF-a, TNF, IL-1</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Hypoglycaemia</p>\n</td>\n<td>\n<p>Ovarian carcinoma</p>\n<p>Fibrosarcoma</p>\n<p>Other mesenchymal sarcomas</p>\n</td>\n<td>\n<p>Insulin or insulin-like substance</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Polycythemia</p>\n</td>\n<td>\n<p>Renal carcinoma</p>\n<p>Cerebellar haemangioma</p>\n<p>Hepatocellular carcinoma</p>\n</td>\n<td>\n<p>Erythropoietin</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Osteomalacia</p>\n</td>\n<td>\n<p>Phosphaturic mesenchymal tumor</p>\n</td>\n<td>\n<p>FGF-23</p>\n</td>\n</tr>\n<tr>\n<td>\n<p>Disseminated intrvascular coagulation</p>\n</td>\n<td>\n<p>Acute promyelocytic leukemia</p>\n<p>Prostatic carcinoma</p>\n</td>\n<td>\n<p>Tumor products activate clotting</p>\n</td>\n</tr>\n</tbody>\n</table><div class=\"table-expand-wrapper\"><button type=\"button\" class=\"table-expand-btn glass-light\">Expand Table</button></div>\n<p>ACTH:&nbsp;Adrenocorticotropic hormone&nbsp;</p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MC7317",
      "difficulty": "medium"
    },
    {
      "text": "A 32-year-old woman presents with a history of palpitations, panic attacks, and difficulty swallowing. Examination reveals a heart rate of 110 bpm, a blood pressure of 156/100 mmHg, and a neck swelling that moves with swallowing. Labs show hypercalcemia, elevated calcitonin, and parathormone levels and an MRI shows bilateral adrenal masses. What gene is responsible for this condition?",
      "choices": [
        {
          "id": 1,
          "text": "p53 tumor suppressor gene"
        },
        {
          "id": 2,
          "text": "MEN I tumor suppressor gene"
        },
        {
          "id": 3,
          "text": "RET proto-oncogene"
        },
        {
          "id": 4,
          "text": "CDKN1B gene"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>This patient most likely has <strong>multiple endocrine neoplasia 2A</strong> (MEN) due to a <strong>gain of function mutation</strong> of <strong>RET proto-oncogene</strong>. </p>\n<p>Palpitations, panic attacks, tachycardia, hypertension with bilateral adrenal masses suggest the presence of a <strong>pheochromocytoma</strong>. Difficulty swallowing and a neck swelling that moves with swallowing along with elevated calcitonin indicated <strong>medullary carcinoma of the thyroid</strong>. Hypercalcemia and elevated PTH could reflect <strong>parathyroid hyperplasia.</strong> Pheochromocytoma, medullary carcinoma of the thyroid, and parathyroid hyperplasia is seen in MEN 2A.</p>\n<p><strong>MEN type 2 </strong>is classified into MEN 2A and MEN 2B. </p>\n<p><strong>MEN 2A</strong> is also called <strong>Sipple syndrome</strong> and characterized by</p>\n<ul>\n<li>Pheochromocytoma</li>\n<li>Medullary carcinoma of the thyroid</li>\n<li>Parathyroid hyperplasia.</li>\n</ul>\n<p><strong>MEN 2B</strong> is characterized by</p>\n<ul>\n<li>Medullary carcinoma of the thyroid</li>\n<li>Pheochromocytoma.</li>\n<li>Mucosal neuromas of lips and tongue, intestinal ganglioneuromas, marfanoid habitus, and lax joints.</li>\n<li><strong>Parathyroid hyperplasia</strong> is <strong>absent</strong>. </li>\n</ul>\n<p>Other options:</p>\n<p>Option B: Mutations in the <strong>MEN1 tumor suppressor gene </strong>lead to<strong> </strong><strong>MEN 1, </strong>also called <strong>Wermer syndrome. </strong> It is characterized by</p>\n<ul>\n<li>Parathyroid hyperplasia or adenoma</li>\n<li>Pancreas - endocrine tumors</li>\n<li>Pituitary - the most common anterior pituitary tumor is prolactinoma</li>\n</ul>\n<p>Option D: <strong>CDKN1B mutations</strong> cause <strong>MEN 4. </strong>This is characterized by clinical features similar to MEN 1.</p>\n<p>Option A: <strong>p53 tumor suppressor gene</strong> mutations can lead to <strong>Li Fraumeni syndrom</strong>e. This is an autosomal dominant hereditary cancer disorder. Patients develop multiple cancers at a young age such as sarcomas, breast cancer, brain tumors, and leukemias.</p><hr><h3>Related Pearl: MEN 1 Syndrome Features</h3><p>Chromosome <strong>11q13 / MEN1 </strong>gene</p>\n<p>Also known as <strong>Wermer&rsquo;s syndrome</strong></p>\n<p>Characteristic tumors seen in:</p>\n<ul>\n<li>Parathyroid adenoma &ndash; 90 % - Most common overall</li>\n<li>Entero pancreatic tumors - Most common functioning tumor is gastrinoma (most common site is duodenum)</li>\n<li>Pituitary adenoma &ndash; Most common is prolactinoma</li>\n<li><strong>Mnemonic</strong> &ndash; Par Pan Pit &ndash; in decreasing order of frequency</li>\n</ul>\n<p>Associated tumors are:</p>\n<ul>\n<li>Angiofibroma</li>\n<li>Collagenomas</li>\n<li>Adrenal cortical tumors</li>\n<li>Lipoma</li>\n<li>Neuroendocrine tumors - gastric, thymic, lungs</li>\n<li>Meningioma</li>\n<li>Pheochromocytoma</li>\n<li>Carcinoid tumors, usually of the foregut</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/95f7c4eac7794f728806926c4f50bbb2x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 2 Syndrome Features</h3><p><strong>MEN 2A</strong></p>\n<ul>\n<li>Known as <strong>Sipple&rsquo;s</strong> syndrome</li>\n<li>Chromosome <strong>10</strong> / <strong>RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Parathyroid adenoma (10&ndash;25%)</li>\n</ul>\n</li>\n</ul>\n<p><strong>MEN 2B</strong></p>\n<ul>\n<li>Known commonly as<strong> MEN 3</strong></li>\n<li>Chromosome<strong> 10/ RET gene</strong></li>\n<li>Associated conditions are:\n<ul>\n<li>Medullary Thyroid Carcinoma (&gt;90%)</li>\n<li>Pheochromocytoma (&gt;50%)</li>\n<li>Other associated abnormalities include: (40&ndash;50%)\n<ul>\n<li>Mucosal neuromas</li>\n<li>Marfanoid habitus</li>\n<li>Medullated corneal nerve fibers</li>\n<li>Megacolon</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/a01742751e314b5fb189a29264e911d3x1280x1061.JPEG\" alt=\"Pearl Image\"><hr><h3>Related Pearl: MEN 4 Syndrome Features</h3><p>It is associated with CDKN1B gene on&nbsp;chromosome 12.</p>\n<p>Associated conditions:</p>\n<ul>\n<li>Parathyroid adenoma</li>\n<li>Pituitary adenoma</li>\n<li>Reproductive organ tumors like testicular cancer, neuroendocrine cervical carcinoma</li>\n<li>Adrenal and renal tumors</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MD7836",
      "difficulty": "medium"
    },
    {
      "text": "The graph below shows the variations in the levels of an adrenocortical hormone over a period of 24 hours. Excessive synthesis of this hormone can lead to which of the following features?",
      "choices": [
        {
          "id": 1,
          "text": "Decreased lipolysis"
        },
        {
          "id": 2,
          "text": "Decreased appetite"
        },
        {
          "id": 3,
          "text": "Decreased cellular immunity"
        },
        {
          "id": 4,
          "text": "Decreased protein catabolism"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>The adrenocortical hormone likely plotted above is <strong>cortisol</strong> as the graph shows a diurnal variation with the maximum peak occurring around 8.00 AM. Excessive synthesis of this hormone<strong> </strong>leads to <strong>decreased</strong> <strong>cellular immunity.</strong> </p>\n<p>Cortisol <strong>suppresses</strong> <strong>cellular immunity</strong> by <strong>inhibiting</strong> the <strong>production</strong> of <strong>IL-2</strong> and <strong>decreasing</strong> the <strong>proliferation</strong> of <strong>T-lymphocytes</strong>. This action is used for suppressing immunity by administering exogenous glucocorticoids to reduce the rejection reactions during transplantation.  </p>\n<p>Cortisol is secreted in a pulsatile fashion and has a <strong>diurnal variation</strong> in its level. The <strong>maximum level occurs in the morning</strong> just before awakening (at around 8.00 AM). It gradually declines later and the <strong>lowest levels</strong> are seen in the evening and midnight, after falling asleep. </p>\n<p><strong>Cortisol</strong> is the major glucocorticoid hormone synthesized in the adrenal cortex, mainly in the zona fasciculata layer. Its <strong>actions </strong>are - </p>\n<p>i) Metabolic effects:</p>\n<ul>\n<li>On carbohydrates: It stimulates gluconeogenesis, increases glycogen synthesis, and decreases the utilization of glucose in peripheral tissues. Thus, excess stimulation of cortisol causes <strong>hyperglycemia. </strong></li>\n<li>On fat: Increases <strong>lipolysis</strong>. </li>\n<li>On protein: Exerts a catabolic effect and causes <strong>proteolysis</strong></li>\n<li>Effect on appetite: Increases the <strong>appetite</strong> and food intake by inducing the synthesis of <strong>neuropeptide-Y</strong>.</li>\n</ul>\n<p>ii) Anti-inflammatory and immunosuppressive effects:</p>\n<ul>\n<li><strong>Induce</strong> the synthesis of <strong>lipocortin</strong>, an inhibitor of phospholipase A2</li>\n<li><strong>Inhibit</strong> the release of <strong>histamine</strong> and <strong>serotonin</strong> </li>\n<li><strong>Inhibit</strong> the production of <strong>IL-2</strong> and <strong>T lymphocytes</strong>, and depresses <strong>cellular immunity</strong></li>\n</ul>\n<p>iii) Maintenance of vascular responsiveness to catecholamines:</p>\n<ul>\n<li>Cortisol up-regulates <strong>α1 receptors</strong> on arterioles, increasing their sensitivity to the <strong>vasoconstrictor</strong> effect of norepinephrine, thereby causing <strong>hypertension</strong> in hypercortisolism. </li>\n</ul>\n<p>iv) Bone formation inhibition by decreasing the type 1 collagen synthesis, intestinal calcium absorption, and osteoblastic activity. </p>\n<p>v) In the central nervous system, cortisol receptors are majorly found in the limbic system. Hence, stimulation of this decreases the rapid eye movement during sleep and increases awake time. Thus, high levels of cortisol are seen in the morning just before awakening.</p>",
      "question_images": [
        "https://cdn1.dailyrounds.org/uploads/9e6c292891ea40b2aec8613acc0f597a.JPEG"
      ],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF4447",
      "difficulty": "medium"
    },
    {
      "text": "A woman presents with a 2-month history of fatigue, muscle weakness, headaches, and palpitations. Her pulse is 75/min, and her blood pressure is 175/92 mm Hg. Physical examination is unremarkable and lab results show serum potassium of 2.8  mEq/L, increased plasma aldosterone levels, and suppressed plasma renin activity. Which of the following tests can confirm the diagnosis?\n",
      "choices": [
        {
          "id": 1,
          "text": "Dexamethasone suppression test"
        },
        {
          "id": 2,
          "text": "Saline infusion test"
        },
        {
          "id": 3,
          "text": "MRI brain"
        },
        {
          "id": 4,
          "text": " Renal duplex scan"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The above clinical scenario along with lab findings suggests <strong>primary hyperaldosteronism</strong>. The diagnosis can be confirmed via <strong>saline infusion test.</strong></p>\n<p>The<strong> saline infusion tes</strong>t is a <strong>confirmatory</strong> test that involves administering intravenous saline to suppress aldosterone secretion. In normal physiology, <strong>increased intravascular volume</strong> from saline should <strong>suppress aldosterone </strong>production. However, in <strong>primary hyperaldosteronism</strong>, aldosterone levels remain<strong> elevated</strong> despite saline infusion, confirming <strong>autonomous</strong> aldosterone production.</p>\n<p><strong>Primary hyperaldosteronism </strong>(Conn syndrome), is characterized by excessive production of aldosterone by the adrenal glands. Patients commonly present with <strong>fatigue</strong>, <strong>muscle weakness</strong>, <strong>headaches</strong>,<strong> palpitations</strong>, and <strong>high blood pressure</strong>. <strong>Hypokalemia</strong> can cause <strong>muscle cramps</strong>, <strong>weakness</strong>, and even paralysis in severe cases. The <strong>diagnosis </strong>is suspected based on <strong>clinical presentation</strong> and laboratory findings of<strong> elevated plasma aldosterone</strong> and <strong>suppressed plasma renin </strong>activity</p>\n<p><strong>Approach to diagnosing hyperaldosteronism:</strong></p>\n<p>Evaluation begins with measuring<strong> plasma aldosterone concentration</strong> (PAC) and<strong> plasma renin activity</strong> (PRA). <strong>Elevated PAC and low PRA </strong> suggest <strong>primary hyperaldosteronism. </strong>E.g. an<strong> adrenal mass </strong>that secretes <strong>aldosterone</strong> will increase PAC and intravascular volume but PRA is reduced because of negative feedback on the JG apparatus.</p>\n<p><strong>Elevated PAC and PRA</strong> indicate hyperaldosteronism due to a <strong>secondary</strong> cause such as <strong>renal artery stenosis</strong><span><strong> </strong></span>in which reduced perfusion to the kidney will activate RAAS and increase both renin and aldosterone.</p>\n<p><strong> Low levels</strong> of <strong>PAC and PRA</strong> suggest <strong>pseudo-hyperaldosteronism</strong>. e.g. The excess cortisol (which has mineralocorticoid activity) in Cushing's will cause symptoms of mineralocorticoid excess but renin and angiotensin will be low because of negative feedback on the RAAS system.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/2b3de5dfb7a54f349201ea0020de6ddex987x1104.PNG\" alt=\"Explanation Image\"><p>Other options: </p>\n<p>Option A: The <strong>dexamethasone suppression test </strong>is test is used for diagnosing <strong>Cushing syndrome</strong>, not primary hyperaldosteronism.</p>\n<p>Option C: An <strong>MRI brain</strong> would be useful to evaluate for <strong>pituitary adenomas.</strong> However, this patient's symptoms make a diagnosis of an <strong>aldosterone secreting tumor</strong> in the <strong>adrenal</strong> more likely.</p>\n<p>Option D: Renal duplex scan is used to diagnose <strong>renal artery stenosis,</strong> which can cause <strong>secondary hyperaldosteronism.</strong></p>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6486",
      "difficulty": "medium"
    },
    {
      "text": "A 3-year-old boy is brought with complaints of abdominal distension for the last 1 month. On examination, an irregular mass is palpated, which is crossing the midline. The patient's blood pressure is normal. Urine examination shows the presence of vanillylmandelic acid and homovanillic acid. Which of the following is the most likely diagnosis in this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Pheochromocytoma"
        },
        {
          "id": 2,
          "text": "Wilms tumor"
        },
        {
          "id": 3,
          "text": "Neuroblastoma"
        },
        {
          "id": 4,
          "text": "Hepatoblastoma"
        }
      ],
      "correct_choice_id": 3,
      "solution": "<p>In the given clinical scenario of a child presenting with a <strong>large abdominal mass</strong> with <strong>normal blood pressure</strong> and <strong>vanillylmandelic acid</strong>&nbsp;(VMA) and <strong>homovanillic acid</strong>&nbsp;(HVA) present <strong>in the urine</strong>, a diagnosis of <strong>neuroblastoma</strong> is most likely.</p>\n<p><strong>Neuroblastoma</strong> is the most frequently diagnosed <strong>malignancy in infancy</strong>. It most commonly arises from the <strong>adrenal glands</strong>, followed by sites along the sympathetic chain, such as the paravertebral region of the abdomen and posterior mediastinum. Neuroblastoma is derived from <strong>primordial neural crest cells</strong> which populate these sites. In young children, they present as large <strong>abdominal masses</strong> with fever and weight loss. They can also metastasize widely and present with symptoms related to other systems.&nbsp;</p>\n<p>90% of neuroblastoma produce <strong>catecholamines</strong>. Urinary levels of <strong>VMA</strong> and <strong>HVA</strong> act as important <strong>tumor markers</strong> and help in making the diagnosis of the disease. Despite the elaboration of catecholamines, <strong>hypertension is less frequent</strong> in these tumors compared to pheochromocytoma. Histologically, neuroblastoma show small, primitive-appearing cells with dark nuclei&nbsp;&mdash; and thus may be difficult to differentiate from other <strong>small round blue cell</strong> tumors. The background shows faintly <strong>eosinophilic fibrillary material (neuropil)</strong> which represents the neuritic processes of the primitive neuroblasts. Around the neuropil, the <strong>tumor cells</strong> are <strong>arranged concentrically</strong>. This is referred to as <strong>Homer-Wright pseudorosettes</strong>.</p>\n<p>Other options:</p>\n<p>Option A: The dominant clinical feature in <strong>pheochromocytoma</strong> is <strong>hypertension</strong>. Most patients have <strong>paroxysmal episodes</strong>, which are abrupt elevations in blood pressure. They are accompanied by <strong>tachycardia</strong>, <strong>palpitations</strong>, <strong>headache</strong>, and sweating. Lab diagnosis of pheochromocytoma is based on the demonstration of <strong>increased urinary excretion</strong> of <strong>free catecholamines</strong> and their metabolites such as <strong>VMA</strong>.</p>\n<p>Option B: <strong>Wilms tumor (nephroblastoma)</strong> usually presents as a <strong>unilateral abdominal mass</strong>, abdominal pain, <strong>hypertension</strong>, and gross <strong>hematuria</strong>. Wilms tumor thrombus can extend into the inferior vena cava and the right atrium. Laboratory findings that can be seen include <strong>polycythemia</strong> and <strong>thrombocytosis</strong>.</p>\n<p>Option D: <strong>Hepatoblastoma</strong> presents as an <strong>asymptomatic mass in the right upper quadrant</strong> of the abdomen. It mostly arises from the right lobe of the liver. Patients have <strong>non-specific symptoms</strong> such as fever, fatigue, weight loss, and anorexia. A biopsy of the liver mass is necessary to make the diagnosis. <strong>Alpha-fetoprotein (AFP)</strong> is a useful tumor marker that is used in diagnosis and monitoring.&nbsp;</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/865333df5e6d4bc6944f21720fcf027cx1280x1096.JPEG\" alt=\"Explanation Image\">",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MF9102",
      "difficulty": "medium"
    },
    {
      "text": "A 33-year-old man collapses during a family vacation. At the hospital, blood pressure is found to be 86/52 mm Hg, and random blood sugar is 49 mg/dl. His wife says that he has been on treatment for Addison's disease for two years but had forgotten to pack his medication for the trip. What is the drug of choice for this patient?",
      "choices": [
        {
          "id": 1,
          "text": "Norepinephrine"
        },
        {
          "id": 2,
          "text": "Hydrocortisone"
        },
        {
          "id": 3,
          "text": "Dexamethasone"
        },
        {
          "id": 4,
          "text": "Fludrocortisone"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>This clinical scenario is suggestive of an<strong> adrenal crisis</strong> triggered by missed medication. In this patient who is a <strong>known</strong> <strong>case</strong> of adrenal insufficiency, <strong>IV hydrocortisone</strong> is the drug of choice.</p>\n<p>However, in patients with <strong>newly diagnosed</strong> adrenal insufficiency, <strong>dexamethasone</strong> is used for the treatment of adrenal crisis. This is because dexamethasone is not measured in cortisol assays and would <strong>not interfere</strong> with the <strong>diagnostic</strong> <strong>tests</strong>, whereas hydrocortisone interferes with cortisol assays.</p>\n<p>Acute adrenal insufficiency requires the immediate initiation of the following therapeutic strategies:</p>\n<ul>\n<li>Rehydration - <strong>saline</strong> infusion at an initial rate of 1 L/h with continuous cardiac monitoring.</li>\n<li><strong>Glucocorticoid</strong> replacement<strong> - </strong>bolus injection of 100 mg hydrocortisone<strong>, </strong>followed by the maintenance dose of 100–200 mg over 24h.</li>\n<li><strong>Mineralocorticoid</strong> replacement - initiated once the daily hydrocortisone dose has been reduced to &lt;50 mg as higher doses of hydrocortisone have sufficient mineralocorticoid action. </li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MB6893",
      "difficulty": "easy"
    },
    {
      "text": "A patient presents with a 3-month history of unintentional weight gain and fatigue. An exam reveals high blood pressure (149/88 mm Hg), central obesity, and abdominal striae. Lab results show elevated 24-hour urinary-free cortisol and suppressed serum ACTH. Which test would most likely confirm the underlying cause of these symptoms?\n",
      "choices": [
        {
          "id": 1,
          "text": "Inferior petrosal sinus sampling"
        },
        {
          "id": 2,
          "text": "CT scan of the abdomen"
        },
        {
          "id": 3,
          "text": "High dose dexa suppression test"
        },
        {
          "id": 4,
          "text": "CT scan of the chest"
        }
      ],
      "correct_choice_id": 2,
      "solution": "<p>The patient's symptoms and lab findings indicate hypercortisolism, likely <strong>Cushing's syndrome</strong>. The <strong>suppressed ACTH </strong>suggests that the source of cortisol is <strong>ACTH-independent</strong>, often due to an <strong>adrenal mass</strong> which can be confirmed with an unenhanced <strong>CT scan of the abdomen</strong>.</p>\n<p>The<strong> diagnostic</strong> evaluation for <strong>Cushing's syndrome</strong> begins with confirming <strong>hypercortisolism</strong> through tests such as the <strong>24-hour urinary free cortisol test</strong>, <strong>overnight dexamethasone suppression test</strong>, or <strong>midnight salivary cortisol test</strong>. Once hypercortisolism is confirmed, the next step is determining whether the cause is <strong>ACTH-dependent</strong> or <strong>ACTH-independent</strong>. This is done by measuring plasma ACTH levels.</p>\n<p>If <strong>ACTH levels are suppressed </strong>it indicates an <strong>ACTH-independent</strong> cause, typically suggesting an adrenal source. Imaging studies, such as a <strong>CT scan of the abdomen</strong>, are performed to identify any <strong>adrenal masses</strong> (e.g., adenomas, carcinomas, or hyperplasia).</p>\n<p>If <strong>ACTH levels are elevated or normal </strong>it suggests an<strong> ACTH-dependen</strong>t cause, possibly due to a <strong>pituitary adenoma</strong> (Cushing's disease) or <strong>ectopic ACTH production</strong>. Further evaluation includes a <strong>high-dose dexamethasone suppression test</strong> and a <strong>CRH stimulation test</strong>. If cortisol levels <strong>decrease</strong> significantly after high-dose dexamethasone and the<strong> CRH test is positive</strong>, it suggests a <strong>pituitary source</strong> (Cushing's disease) which can be confirmed with an MRI. If cortisol levels <strong>are not suppressed</strong>, and the <strong>CRH test is negative</strong> the patient should be evaluated for<strong> ectopic ACTH production</strong>. In case of <strong>equivocal results</strong>, an<strong> Inferior petrosal sinus sampling</strong> may be performed to differentiate the two causes.</p><img src=\"https://dhmbxeygs57ff.cloudfront.net/uploads/85809380960f4804a98cadbd31d24b80x1200x2435.JPEG\" alt=\"Explanation Image\"><p><br />Other options: </p>\n<p>Option A: <strong>Inferior petrosal sinus sampling</strong> is used to differentiate between <strong>pituitary</strong> and <strong>ectopic</strong> sources of ACTH in <strong>ACTH-dependent Cushing's</strong></p>\n<p>Option C: <strong>High-dose dexamethasone suppression test</strong> differentiates <strong>pituitary </strong>and <strong>ectopic ACTH</strong> production in <strong>ACTH-dependent Cushing's</strong>.</p>\n<p>Option D:<strong> </strong>A <strong>CT scan</strong> of the chest may be used to identify <strong>ectopic ACTH source</strong>, most commonly <strong>small cell lung carcinoma</strong>, which is unlikely given the <strong>suppressed ACTH levels</strong>.</p><hr><h3>Related Pearl: Causes of Cushing's Syndrome</h3><p><strong>Exogenous causes </strong>(iatrogenic)</p>\n<ul>\n<li>Prolonged administration of glucocorticoids (most common cause of Cushing's)</li>\n</ul>\n<p><strong>Endogenous causes</strong></p>\n<ul>\n<li><strong>ACTH independent </strong>(primary hypercortisolism)\n<ul>\n<li>Adrenocortical adenoma&nbsp;</li>\n<li>Adrenocortical carcinoma&nbsp;</li>\n<li>Bilateral adrenal hyperplasia</li>\n</ul>\n</li>\n</ul>\n<ul>\n<li><strong>ACTH dependent&nbsp;</strong>(secondary hypercortisolism)\n<ul>\n<li><strong>Cushing&rsquo;s disease:&nbsp;</strong>ACTH secreting&nbsp;<strong>pituitary adenoma </strong>(most common cause of endogenous Cushing's)</li>\n<li><strong>Paraneoplastic causes: </strong>Ectopic ACTH secreting tumors\n<ul>\n<li><strong>Small-cell lung carcinoma</strong></li>\n<li>Bronchial or pancreatic carcinoid tumors</li>\n<li>Medullary thyroid carcinoma</li>\n<li>Pheochromocytoma</li>\n</ul>\n</li>\n</ul>\n</li>\n</ul>\n<p><strong>Rare causes</strong></p>\n<ul>\n<li>Macronodular adrenal hyperplasia</li>\n<li>Primary pigmented nodular adrenal disease</li>\n<li>McCune <strong>&ndash;</strong> Albright syndrome</li>\n</ul><hr><h3>Related Pearl: Initial Tests for Diagnosing Cushing's Syndrome</h3><p>These include two steps:</p>\n<p><strong>1. Tests to detect hypercortisolism</strong></p>\n<ul>\n<li><strong>Midnight salivary or serum cortisol</strong> (highly sensitive test):<strong>&nbsp;</strong>The presence of cortisol in the saliva or serum at midnight signifies loss of diurnal variation of cortisol</li>\n<li><strong>24-hour urinary free cortisol excretion</strong>:&nbsp;Increased three times the normal value</li>\n<li><strong>Overnight dexamethasone suppression test</strong> (DST):&nbsp;Plasma cortisol &gt;1.8 &mu;g/dL at 8 a.m after overnight exposure to dexamethasone (1 mg given at 11 p.m)</li>\n<li><strong>Low dose DST</strong> (highly specific test):&nbsp;Plasma cortisol &gt;1.8 &mu;g/dL at 8 a.m. on the third day after giving 0.5 mg dexamethasone every 6 hours for 2 days</li>\n</ul>\n<p><strong>2. Test </strong><strong>to rule out pseudo Cushing's syndrome</strong></p>\n<ul>\n<li><strong>Low-dose DST + CRH stimulation test</strong>: Plasma cortisol levels are increased in true Cushing&rsquo;s but remain unaffected in pseudo Cushing's.&nbsp;Dexa-induced negative feedback is overcome by CRH in true Cushing&rsquo;s.</li>\n</ul>",
      "question_images": [],
      "explanation_images": [],
      "explanation_video": null,
      "question_id": "MG6483",
      "difficulty": "medium"
    }
  ]
}